| Literature DB >> 32657090 |
Latika Gupta1, Armen Yuri Gasparyan2, Durga Prasanna Misra1, Vikas Agarwal1, Olena Zimba3, Marlen Yessirkepov4.
Abstract
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has led to a large volume of publications, a barrage of non-reviewed preprints on various professional repositories and a slew of retractions in a short amount of time.Entities:
Keywords: COVID-19; Coronavirus Disease 2019; Information; Periodicals as Topic; Publishing; Social Media
Mesh:
Year: 2020 PMID: 32657090 PMCID: PMC7358067 DOI: 10.3346/jkms.2020.35.e256
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
Coronavirus disease 2019 information and misinformation survey respondent characteristics
| Characteristics | Respondents (n = 128) | ||
|---|---|---|---|
| Age, yr | 43.2 | ||
| Sex | |||
| Female | 60 (46.9) | ||
| Male | 68 (53.1) | ||
| Are you the editor/editorial board member for a journal? | |||
| No. | 79 (61.7) | ||
| Editorial board member | 44 (34.4) | ||
| Editor | 16 (12.5) | ||
| Years post medical school, average | 19.8 | ||
| Job profile | |||
| Academician | 69 (53.9) | ||
| Doctor | 80 (62.5) | ||
| Researcher | 42 (32.8) | ||
| Specialty | |||
| Rheumatology | 42 (32.8) | ||
| Physical medicine and rehabilitation | 14 (10.9) | ||
| Cardiology | 8 (6.3) | ||
| Others | 8 (6.3) | ||
| Internal medicine | 7 (5.5) | ||
| Paediatrics | 6 (4.7) | ||
| Immunology | 4 (3.1) | ||
| Public health | 4 (3.1) | ||
| Obstetrics and gynaecology | 4 (3.1) | ||
| Family and general medicine | 3 (2.3) | ||
| Endocrinology | 2 (1.6) | ||
| General practice | 2 (1.6) | ||
| Neurology | 2 (1.6) | ||
| Respiratory medicine | 2 (1.6) | ||
| General surgery | 2 (1.6) | ||
| Urology | 2 (1.6) | ||
| Pathology | 2 (1.6) | ||
| Pharmacology | 2 (1.6) | ||
| Accident and emergency medicine | 1 (0.8) | ||
| Anaesthetics | 1 (0.8) | ||
| Gastroenterology | 1 (0.8) | ||
| Hematology | 1 (0.8) | ||
| Nephrology | 1 (0.8) | ||
| Preventive medicine | 1 (0.8) | ||
| Gastroenterologic surgery | 1 (0.8) | ||
| Thoracic surgery | 1 (0.8) | ||
| Laboratory medicine | 1 (0.8) | ||
| Radiology | 1 (0.8) | ||
| Clinical biology | 1 (0.8) | ||
| Clinical chemistry | 1 (0.8) | ||
| Country | |||
| India | 41 (32.0) | ||
| Turkey | 33 (25.8) | ||
| Kazakhstan | 14 (10.9) | ||
| Ukraine | 6 (4.7) | ||
| United States | 6 (4.7) | ||
| Russia | 5 (3.9) | ||
| Bulgaria | 3 (2.3) | ||
| Croatia | 3 (2.3) | ||
| United Kingdom | 3 (2.3) | ||
| Pakistan | 2 (1.6) | ||
| Australia | 1 (0.8) | ||
| Canada | 1 (0.8) | ||
| Egypt | 1 (0.8) | ||
| Greece | 1 (0.8) | ||
| Iran | 1 (0.8) | ||
| Italy | 1 (0.8) | ||
| Malaysia | 1 (0.8) | ||
| Mexico | 1 (0.8) | ||
| Peru | 1 (0.8) | ||
| Poland | 1 (0.8) | ||
| Romania | 1 (0.8) | ||
| Spain | 1 (0.8) | ||
Values are presented as number (%) or average.
Analysis of survey results on COVID-19 information and misinformation
| Questions | Respondents (n = 128) | |
|---|---|---|
| On which resources/platforms have you found information on COVID-19? | ||
| TV | 58 (41.4) | |
| Digital libraries | 12 (51.6) | |
| Publishers' repositories | 13 (46.9) | |
| Information Aggregators | 21 (22.7) | |
| Social media channels | 86 (63.3) | |
| Other | 5 (6.3) | |
| On which resources/platforms have you found misinformation on COVID-19? | ||
| TV | 58 (45.3) | |
| Digital libraries | 12 (9.4) | |
| Publishers' repositories | 13 (10.2) | |
| Information aggregators | 21 (16.4) | |
| Social media channels | 86 (67.2) | |
| Other | 5 (3.9) | |
| All of these | 34 (26.6) | |
| Who is responsible for misinformation in scholarly journals during the pandemic? | ||
| Authors | 83 (64.8) | |
| Reviewers | 61 (47.7) | |
| Editors | 62 (48.4) | |
| Commercial editing agencies involved in editing and submitting manuscripts | 62 (48.4) | |
| Social media accounts of scholarly journals | 54 (42.2) | |
| Misinterpretation by readers | 61 (47.7) | |
| No one | 8 (6.3) | |
| Other | 3 (2.3) | |
| Can we rely on non-reviewed (unpublished) items posted on preprints (e.g. medRxiv, bioRxiv) and amend our preventative and curative approaches? | ||
| Yes | 3 (2.3) | |
| No | 65 (50.8) | |
| Sometimes | 38 (29.7) | |
| I am not sure | 18 (14.1) | |
| What are pre-prints? | 4 (3.1) | |
| In changing times like this, where rapid dissemination of scientific information is vital, what are your thoughts on peer review at scholarly journals? | ||
| It is mandatory for quality control | 80 (62.5) | |
| Causes unnecessary delay in the publication of potentially valuable data | 8 (6.3) | |
| Somewhat helpful-should be at the discretion of the editor-in-chief | 25 (19.5) | |
| I am not sure | 15 (11.7) | |
| Do you think plagiarism may become more rampant in the current pandemic, with the publish or perish dictum? | ||
| Yes | 75 (58.6) | |
| No | 11 (8.6) | |
| I am not sure | 42 (32.8) | |
| What kind of plagiarism do you expect the most in these times? | ||
| Self-plagiarism | 36 (28.1) | |
| Paraphrasing plagiarism | 70 (54.7) | |
| Verbatim plagiarism | 29 (22.7) | |
| Graphics copying | 45 (35.2) | |
| Plagiarism of ideas | 82 (64.1) | |
| Mosaic plagiarism | 28 (21.9) | |
| Incorrect citation | 46 (35.9) | |
| I am not aware of these | 3 (2.3) | |
| I am not sure | 15 (11.7) | |
| None | 1 (0.8) | |
| Who do you feel is more likely to plagiarize? | ||
| Prolific researchers | 21 (16.4) | |
| Novice researchers | 56 (43.8) | |
| Agents of commercial editing companies | 66 (51.6) | |
| Everyone | 47 (36.7) | |
| No-one | 4 (3.1) | |
| Do you have solutions to avoid plagiarism in such times? | ||
| Conventional cyber police | 13 (10.2) | |
| Editors should screen and recheck submissions more attentively | 79 (61.7) | |
| Plagiarism software providers grant open-access for this period | 76 (59.4) | |
| Set up new academic police | 24 (18.8) | |
| Building new artificial intelligence driven software | 56 (43.8) | |
| I am not sure | 16 (12.5) | |
| None | 3 (2.3) | |
| Other | 2 (1.6) | |
| How should retraction rates change during a pandemic situation? | ||
| There should be a lower threshold for retraction given the sensitive situation | 30 (23.4) | |
| There should be a higher threshold for retraction given the difficulty in conducting meticulous research | 40 (31.3) | |
| I am not sure | 47 (36.7) | |
| No change | 11 (8.6) | |
| Is there is a need to launch a specialist database on coronaviruses? | ||
| Yes | 95 (74.2) | |
| No | 18 (14.1) | |
| I am not sure | 15 (11.7) | |
| Which are the main trustworthy journals covering the pandemic? | ||
| NEJM | 66 (51.6) | |
| Nature | 63 (49.2) | |
| Science | 43 (33.6) | |
| Lancet | 68 (53.1) | |
| BMJ | 55 (43.0) | |
| JAMA | 49 (38.3) | |
| I am not sure | 29 (22.7) | |
| Other | 6 (4.7) | |
| How can misinformation be tackled? | ||
| Set up common platform with verified information | 81 (63.3) | |
| More stringent peer review (higher number of reviewers) | 87 (68.0) | |
| Higher rejection rate | 30 (23.4) | |
| Higher retraction rate | 17 (13.3) | |
| Other | 7 (5.5) | |
| Who should the common platform for verified information comprise of? | ||
| Academicians | 85 (66.4) | |
| Editors | 67 (52.3) | |
| All kinds of doctors | 42 (32.8) | |
| Students | 9 (7.0) | |
| Information facilitators (librarians) | 24 (18.8) | |
| All mentioned | 41 (32.0) | |
| No-one | 1 (0.8) | |
| How global bibliographic databases (MEDLINE/PubMed, Scopus, Web of Science) may respond to the pandemic? (multiple answers) | ||
| Contribute more to the Open Access global initiative (make all articles related to COVID-19 available free of cost and archived by PubMed Central) | 106 (82.8) | |
| Expand search terms (like MeSH terms) for COVID-19 related searches | 67 (52.3) | |
| Delineate highly accessed articles on COVID-19 | 50 (39.1) | |
| Delineate articles with meticulous methods | 43 (33.6) | |
| Other (please specify) | 4 (3.1) | |
Values are presented as number (%).
COVID-19 = coronavirus disease 2019.
Fig. 1Perception of sources of misinformation, plagiarism, and reliability of preprints by physicians and academics.
COVID-19 = coronavirus disease 2019.